The prevalence of HCM in young adults is approximately 2 per 1000, providing foundational data for population screening strategies.
Answers are grounded in this paper and cite their sources.
Provides foundational prevalence data for HCM in young adults; leaves open whether screening improves outcomes.
HCM was present in about 2 of 1000 young adults. These unique population-based data will aid in assessments of the impact of HCM-related mortality and morbidity in the general population and the practicality of screening large populations for HCM, including those comprising competitive athletes.
No takes yet. Share an insight, caveat, or question.
Maron et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: